|
Non
|
(2-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)phenyl)boronik asid
|
|---|---|
|
Sinonim
|
(2-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)phenyl) asid boronik;
(2-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)phenyl)boronik asid;
Asid bornik, B-[2-[(4,5-dimethyl-3-izoxazolyl) (methoxymethyl)amino]sulfonyl]fenil;
|
|
CAS
|
415697-58-4
|
|
MF
|
C₁₃H₁₇BN₂O₆S
|
|
mw
|
340.16
|
|
Itilizasyon
|
Entèmedyè pou inibitè kinaz R & D: Kòm yon entèmedyè pharmaceutique kle ak yon estrikti asid boronik, gwoup asid boronik li yo ka prezante nan molekil sib atravè reyaksyon Suzuki kouple, fasilite sentèz la nan timè-inibitè kinaz ki gen rapò tankou reseptè faktè kwasans epidèm (EGFR) ak anaplastic lenfom kinaz (ALK) inibitè, epi bay yon inibitè precision devlopman nan dwòg.
Echafodaj molekilè pou dwòg anti-enflamatwa: Bag isoxazol ak gwoup sulfamoyl nan estrikti a genyen potansyèl aktivite anti{0}}enflamatwa. Modifikasyon estriktirèl ka kontwole efè inhibition konpoze an sou chemen enflamatwa, sa ki pèmèt devlopman nouvo dwòg pou maladi otoiminitè tankou atrit rimatoyid ak kolit ilsè.
|
Baj popilè: cas:415697-58-4 (2-(n-(4,5-dimethylisoxazol-3-yl)-n-(methoxymethyl)sulfamoyl)phenyl) asid boronik, Lachin, manifaktirè, founisè, faktori, koutim, wholesale
